Antihyperglycaemic drugs are beneficial for people with type 2 diabetes and chronic obstructive pulmonary disease – DiabetesTimes.co.uk

GLP-1 receptor agonists and SGLT-2 inhibitors are more beneficial than sulfonylureas for people with chronic obstructive pulmonary disease and type 2 diabetes, according to research published in the British Medical Journal.
During the study, the academics assessed the health outcomes of thousands of people using GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors and sulfonylureas.
They found that GLP-1 receptor agonists were associated with a 30 per cent decreased risk of severe exacerbation compared to sulfonylureas.
In addition, they discovered that DPP-4 inhibitors were associated with a modestly decreased incidence of severe exacerbation.
Meanwhile, SGLT-2 inhibitors were associated with a 38 per cent decreased risk of severe exacerbation, the study has reported.
The research states: “In this population-based study, GLP-1 receptor agonists and SGLT-2 inhibitors were associated with a reduced risk of severe exacerbations compared with sulfonylureas in people with chronic obstructive pulmonary disease and type 2 diabetes.
“DPP-4 inhibitors were not clearly associated with a decreased risk of chronic obstructive pulmonary disease exacerbations.”
Click here to read the research report.
Register an account or login to comment
Diabetes UK issues latest guidance on coronavirus
People with diabetes urged to be ‘particularly stringent’ amid COVID-19 pandemic
NHS Drug Tariff approval for FreeStyle Libre System
Updated metformin and B12 guidance published
Criticism over Eatwell Plate amid calls for low carb approach
Type 1 man no longer requires insulin
Man commended for living with diabetes for 80 years
Warning over Lucozade sugar reduction
FreeStyle® Libre 2 includes optional real-time alarms
Novo Nordisk UK launches Ozempic® (semaglutide)
GLP-1RA receptor agonists and SGLT2 inhibitors beneficial for managing type 1 diabetes
Long-term cardiovascular problems triggered by gestational diabetes, study demonstrates
Antihyperglycaemic drugs are beneficial for people with type 2 diabetes and chronic obstructive pulmonary disease
Global scientific experts to advise on £50 million investment into type 1 diabetes research
Once-weekly semaglutide helps combat teenage obesity, evidence identifies
Retired optometrist puts diabetes technologies under the spotlight in latest Big Interview
Welsh type 2 diabetes patients are missing out on vital free education
New book on type 1 diabetes technology published
Leading diabetes conference gives ‘vital boost’ to care
FDA approves first drug that can delay onset of type 1 diabetes
Paediatric Diabetes Dietitian
Band 7 Midwife in Diabetes
Advanced Podiatrist in Diabetes
Paediatric Diabetes Dietitian
Diabetes Specialist Nurse
Consultant in Diabetes and Endocrinology
Diabetes Support Worker (South West & South Central)
Digital Engagement Officer (South West & South Central)
Diabetic Specialist Midwife
Paediatric Diabetes Clinical Nurse Specialist & Transitional Care Lead

The Diabetes Times © 2022

source